Aarti Drugs surges on robust Q4 earnings

Q4 profit up 86% at Rs 13.81 crore against Rs 7.41 crore in year ago quarter.

Image
SI Reporter Mumbai
Last Updated : May 17 2013 | 10:36 AM IST
Aarti Drugs is locked in upper circuit of 10% at Rs 210 on NSE after reporting a robust 86% year-on-year (y-o-y) jump in net profit at Rs 13.81 crore for the fourth quarter ended March 31, 2013.

The pharmaceutical company had reported a profit of Rs 7.41 crore in the year ago quarter. Net sales grew 10.6% at Rs 220 crore on y-o-y basis.

For the full financial year 2012-13, net profit more-than-doubled to Rs 45.24 crore against profit of Rs 22.46 crore in FY2011-12. Net sales surged 25% at Rs 826 crore from Rs 662 crore in previous year.

Meanwhile, the board has recommended a final dividend of Rs 4 per share on equity shares of Rs 10 each.

The stock opened at Rs 202 and has seen a combined 14,537 shares changing hands on the counter so far. There are pending buy orders for 9,683 shares on NSE and BSE at 0945 hours.
 

More From This Section

First Published: May 17 2013 | 9:46 AM IST

Next Story